[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336827-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336827-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","role-and-molecular-mechanisms-of-huangqisijunzi-decoction-for-treating-triple-negative-breast-cancer-research-open-access","Role and molecular mechanisms of HuangQiSiJunZi decoction for treating triple-negative breast cancer - Research Open Access","","This study evaluates the molecular mechanisms of HuangQiSiJunZi Decoction (HQSJZD) in treating triple-negative breast cancer (TNBC) through network pharmacology and bioinformatics. Active chemical components and targets were selected using TCMSP, while TNBC differential genes were extracted from TCGA. A PPI network and hub genes were identified and validated in GEO, followed by enrichment analyses and Cox regression to build a logistic prediction model. Immune infiltration differences and RT-qPCR validation supported key gene associations, with a FOS-based prognostic signature suggesting immune-related therapeutic potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/role-and-molecular-mechanisms-of-huangqisijunzi-decoction-for-treating-triple-negative-breast-cancer-research-open-access/336827/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/role-and-molecular-mechanisms-of-huangqisijunzi-decoction-for-treating-triple-negative-breast-cancer-research-open-access/336827.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study objective regarding HuangQiSiJunZi decoction and TNBC?","Question",{"text":63,"@type":64},"To evaluate the molecular mechanisms of HuangQiSiJunZi Decoction (HQSJZD) for treating triple-negative breast cancer (TNBC) using network pharmacology and bioinformatics analyses.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers identify potential targets and genes?",{"text":68,"@type":64},"They selected effective chemical components and action targets from TCMSP, extracted TNBC differential expressed genes from TCGA, built a PPI network to find hub genes, and verified hub gene expression using GEO datasets.",{"name":70,"@type":61,"acceptedAnswer":71},"What key biomarkers and immune findings were reported?",{"text":72,"@type":64},"The work predicted multiple targets and identified 16 TNBC hub genes, with a prognostic signature involving FOS, MMP9, and PGR. Immune infiltration differed across seven immune cell types, and RT-qPCR validation supported the bioinformatics results for FOS.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336827,1790218387,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Wang et al. BMC Cancer (2024) 24:1217 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-12957-5](https://doi.org/10.1186/s12885-024-12957-5)  \nRESEARCH Open Access  \nRole and molecular mechanisms of HuangQiSiJunZi decoction for treating triple-negative breast cancer as explored via network pharmacology and bioinformatics analyses  \nDecai Wang 1, Dongqing Xie2†, Shuai Meng3†, Jiwei MI4, Haiming Wang3, Lingsheng Li3, Yin Zhang3* andYixin Cui3*  \nAbstract  \nObjective In this study, we evaluated the molecular mechanisms of HuangQiSiJunZi Decoction (HQSJZD) for treating triple-negative breast cancer (TNBC) using network pharmacology and bioinformatics analyses.  \nMethods Effective chemical components together with action targets of HQSJZD were selected based on the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) . Meanwhile, differential ly expressed genes (DEGs) were extracted from TNBC sample data in The Cancer Genome Atlas (TCGA) database. Additionally, we built a protein-protein interaction (PPI) network and acquired hub genes. Gene Expression Omnibus(GEO) datasets were utilized to verify the accuracy of hub gene expression. Additionally, enrichment analyses were conducted on key genes. Furthermore, TNBC severity-related high-risk factors were screened through univariate together with multivariate Cox regressions; next, the logistic regression prediction model was built. Moreover, differential levels of 22 immune cell types inTNBC tissues compared with normal tissues were analyzed. The hub gene levels within pan-cancer and the human body were subsequently visualized and analyzed. Finally, quantitative PCR (RT-qPCR) was used to validate the correlation of the hub genes inTNBC cells.  \nResults The study predicted 256 targets of active ingredients and 1791 DEGs inTNBC, and obtained 16 hub genes against TNBC. The prognostic signature based on FOS, MMP9, and PGR was independent in predicting survival. A total of seven types of immune cells, such as CD4 + memory T cells, showed a significant difference in infiltration (p \u003C 0. 05), and immune cells were related to the hub genes. The HPA database was adopted for hub gene analyses, and as determined, FOS was highly expressed in most human organs. The results of RT-qPCR validation for the FOS hub gene were consistent with those of bioinformatic analyses.  \n†Dongqing Xie and Shuai Meng co-first author.  \n*Correspondence:  \nYin Zhang [zhangyin@301hospital.com.cn](zhangyin@301hospital.com.cn)[ ](zhangyin@301hospital.com.cn)Yixin Cui [cuiyixin@301hospital.com.cn](cuiyixin@301hospital.com.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://](http://)[ ](http://)[creativecommons.org/l](creativecommons.org/l)icenses/by-nc-nd/4.0/.  \nWang et al. BMC Cancer (2024) 24:1217 Page 2 of 21  \nConclusion HQSJZD might regulate the interleukin-17 and aging pathways via FOS genes to increase immune cell infiltration inTNBC tissues, and thus, may treat TNBC a","cbCaidOY54F6kffH","https://ap.wps.com/l/cbCaidOY54F6kffH","pdf",11666789,21,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the study objective regarding HuangQiSiJunZi decoction and TNBC?\",\"answer\":\"To evaluate the molecular mechanisms of HuangQiSiJunZi Decoction (HQSJZD) for treating triple-negative breast cancer (TNBC) using network pharmacology and bioinformatics analyses.\"},{\"question\":\"How did the researchers identify potential targets and genes?\",\"answer\":\"They selected effective chemical components and action targets from TCMSP, extracted TNBC differential expressed genes from TCGA, built a PPI network to find hub genes, and verified hub gene expression using GEO datasets.\"},{\"question\":\"What key biomarkers and immune findings were reported?\",\"answer\":\"The work predicted multiple targets and identified 16 TNBC hub genes, with a prognostic signature involving FOS, MMP9, and PGR. Immune infiltration differed across seven immune cell types, and RT-qPCR validation supported the bioinformatics results for FOS.\"}]","Role and molecular mechanisms of HuangQiSiJunZi decoction for treating triple-negative breast cancer - Research Open Access | PDF",1790016761,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5fc6fc7f74f7b77fef644b5008146fd1.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45690ae0ba4df02063a5a5bcb2cde931.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f55f8a85d507725542d77a3c717bbd0.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b227e49d3b736d4c35a0967f4ef3cd0b.webp",980,1306]